GLA
HAE icon

Great Lakes Advisors’s Haemonetics HAE Stock Holding History

Great Lakes Advisors’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-21,740
Closed -$1.7M – 826
2024
Q4 		$1.7M Sell
21,740
-1,092
-5% -$87.7K 0.01% 497
2024
Q3 		$1.84M Sell
22,832
-136,508
-86% -$11M 0.02% 496
2024
Q2 		$13.2M Sell
159,340
-8,210
-5% -$722K 0.12% 167
2024
Q1 		$14.3M Sell
167,550
-1,705
-1% -$134K 0.12% 167
2023
Q4 		$14.5M Sell
169,255
-28,168
-14% -$2.44M 0.14% 162
2023
Q3 		$17.7M Buy
197,423
+17,560
+10% +$1.57M 0.16% 132
2023
Q2 		$15.3M Buy
179,863
+16,569
+10% +$1.4M 0.15% 153
2023
Q1 		$13.5M Buy
163,294
+143,942
+744% +$11.7M 0.12% 156
2022
Q4 		$1.52M Sell
19,352
-8,651
-31% -$695K 0.09% 338
2022
Q3 		$2.07M Sell
28,003
-252
-0.9% -$18.1K 0.05% 343
2022
Q2 		$1.84M Buy
28,255
+2,931
+12% +$173K 0.04% 375
2022
Q1 		$1.6M Sell
25,324
-2,838
-10% -$154K 0.03% 405
2021
Q4 		$1.49M Sell
28,162
-1,387
-5% -$84.5K 0.02% 411
2021
Q3 		$2.09M Buy
+29,549
New +$1.86M 0.03% 374

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Great Lakes Advisors's HAE Position: Q1 2025 in Review

Great Lakes Advisors sold out of Haemonetics (HAE) in Q1 2025, closing a stake of 21,740 shares — an estimated $1.7M sold.

Great Lakes Advisors first reported a position in HAE in Q3 2021 and held it in 14 quarters. The position peaked at $17.7M in Q3 2023. 314 funds tracked by Wall St. Rank hold HAE as of Q1 2025.

  • Great Lakes Advisors reported no remaining Haemonetics position as of Q1 2025 after selling out during the quarter.
  • Great Lakes Advisors sold 21,740 Haemonetics shares in Q1 2025, an estimated $1.7M.
  • Great Lakes Advisors first reported a position in Haemonetics in Q3 2021 and held it in 14 quarters.
  • Great Lakes Advisors's Haemonetics position peaked at $17.7M in Q3 2023.
  • 314 funds tracked by Wall St. Rank held Haemonetics as of Q1 2025.

Based on Great Lakes Advisors's 13F filing for Q1 2025, filed 16 May 2025.